MGRM Monogram Orthopaedics
- 2.000
- -0.040-1.96%
- 1.999
- -0.001-0.06%
Monogram Orthopaedics News
Monogram Technologies Inc. (MGRM) Q3 2024 Earnings Call Transcript
Will Monogram Technologies (NASDAQ:MGRM) Spend Its Cash Wisely?
Monogram Technologies Q3 EPS $(0.16) Down From $(0.03) YoY
Monogram Orthopaedics | 10-Q: Q3 2024 Earnings Report
Earnings Preview: MGRM to Report Financial Results Post-market on November 19
$Monogram Orthopaedics(MGRM.US)$ is scheduled to release its financial results post-market on November 19 ET. Earnings PreviewAnalysts estimate $Monogram Orthopaedics(MGRM.US)$ to post revenue of USD0
Monogram Technologies to Host Third Quarter 2024 Results Conference Call on Tuesday, November 19, 2024 at 4:30 P.m. Eastern Time
Monogram Technologies Named Orthopedic Joint Replacement Company of the Year 2024
Monogram Technologies to Present at the LD Micro Main Event XVII Conference on Wednesday October 30, 2024
Monogram Orthopaedics Clarifies FDA Response Timeline
Monogram Technologies Announces Closing of Upsized and Oversubscribed $13 Million Public Offering
Monogram Technologies Receives FDA Response for MBôs TKA System
Monogram Orthopaedics Secures Funding and Pursues FDA Approval
Express News | Monogram Technologies: Got Additional Information Request From FDA on Sept 30, for Its 510(K) Premarket Filing Submission for Mbôs Tka System
Monogram Orthopaedics Announces Quarterly Preferred Dividend
Monogram Orthopaedics Expands Offering for Corporate Growth
Monogram Technologies Upsizes 8.00% Series D Convertible Cumulative Preferred Stock and Warrant Offering to $12.5 Million
Monogram Orthopaedics | 10-Q: Q2 2024 Earnings Report
Monogram Technologies Q2 GAAP EPS $(0.11) Misses $(0.09) Estimate
Monogram Technologies Announces Collaboration With Shalby Limited for Multicenter Clinical Trial | NASDAQ:MGRM
Monogram Orthopaedics Announces Strategic Collaboration With Shalby
Analysis
Price Target
No Data
No Data